We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MS Technology Develops into an Accessible Platform

By Biotechdaily staff writers
Posted on 10 Jun 2008
Mass spectrometry (MS), which was until recently a complicated technology available exclusively to highly trained experts, is today a workhorse analytic technique for a wide variety of scientific applications including food and environmental contamination testing, forensic analysis, drug discovery and development, and basic research.

The development of this MS technology into an accessible platform for scientists across disciplines was the focus for Applied Biosystems (Warrington, UK) and its joint venture partner, MDS Analytical Technologies (Sunnyvale, CA, USA) during the 56th annual American Society of Mass Spectrometry (ASMS) conference in Denver, May 31-June 5, 2008.

Applied Biosystems/MDS Analytical Technologies' scientists presented more than 70 presentations highlighting recent and ongoing investigations enabled by their technology platforms at the meeting. More...
The presentations illustrated how newly released software applications and chemical reagents deliver complete, integrated workflows for applications ranging from the discovery, validation, and verification of biomarkers to drug metabolism studies, and the detection and measurement of environmental contaminants.

At the meeting Ethan Badman, Ph.D., principal scientist at Hoffman-La Roche (Nutley, NJ, USA) described a new, automated method using MS that allows a one-touch approach to determining matrix factors. Calculation of matrix factors provides a clear understanding of the matrix effects in bioanalytical assays. "The procedure developed by Applied Biosystems essentially lets us open a template, click, and get the matrix factors we need,” said Dr. Badman. "It is much easier because it is all automated, compared to calculating matrix factors manually. The fact that the algorithm is built-in reduces calculation errors.”

Christie Hunter, Ph.D., a senior staff scientist at Applied Biosystems, reviewed how the joint venture's integration of hardware, software, and reagents could be used to reproducibly quantitate hundreds of proteins for targeted proteomics applications, including biomarker studies. This extends the targeted proteomics approach, which is being called the fourth generation of proteomics.

Applied Biosystems hosted a number of workshops, including one that concentrated on the value of integrated services for validation and remote system monitoring for regulated laboratories. This workshop provided an overview of the U.S. Food and Drug Administration's trends for laboratory compliance, and highlighted the availability of an expanded range of Smart Monitoring and Compliance services from Applied Biosystems Global Services.

Applied Biosystems/MDS Analytical Technologies' expanded suite of powerful mass spectrometry software and solutions to increase scientific productivity were also on display during the meeting.


Related Links:
Applied Biosystems
MDS Analytical Technologies
Hoffman-La Roche

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.